Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Faga Daniel Insider Profile
4 Followers
Faga Daniel, CBO at Spark Therapeutics, holds 26.24K shares in Mirati Therapeutics (Ticker: MRTX), holds 0.00 shares in Spark Therapeutics (Ticker: ONCE).
Faga Daniel Spark Therapeutics (ONCE)CBO
Spark Therapeutics (ONCE)
CBO
Not Ranked
Faga Daniel has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
EVP, Chief Operating Officer
Roles that Faga Daniel holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Faga Daniel
Faga Daniel's Trading History
Spark Therapeutics
Dec 17, 2019
―
Uninformative Sell
4.45M
$0.00
Mirati Therapeutics
Jan 08, 2020
EVP, Chief Operating Officer
Uninformative Buy
―
$6.10M
List of latest transactions for each holding click on a transaction to see Faga Daniel's performance on stock
You May Also Like
Faga Daniel insider profile FAQ
What is the percentage of profitable transactions made by Faga Daniel?
The percentage of profitable transactions made by Faga Daniel is ―.
What is the average return per transaction made by Faga Daniel?
The average return per transaction made by Faga Daniel is ―.
What stocks does Faga Daniel hold?
Faga Daniel holds: ONCE, MRTX stocks.
What was Faga Daniel’s latest transaction?
Faga Daniel latest transaction was an Uninformative Buy of ―.
What was Faga Daniel's most profitable transaction?
Faga Daniel’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Faga Daniel's role in Spark Therapeutics?
Faga Daniel's role in Spark Therapeutics is CBO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.